These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22008818

  • 21. Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus.
    Kulkarni R, Sapkal G, Mahishi L, Shil P, Gore MM.
    Virus Res; 2012 Jun; 166(1-2):77-86. PubMed ID: 22445688
    [Abstract] [Full Text] [Related]

  • 22. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodríguez F.
    Vaccine; 2006 May 01; 24(18):3889-99. PubMed ID: 16563575
    [Abstract] [Full Text] [Related]

  • 23. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.
    Gene Ther; 2003 Dec 01; 10(25):2059-66. PubMed ID: 14595378
    [Abstract] [Full Text] [Related]

  • 24. An adenovirus-herpes simplex virus glycoprotein B recombinant (Ad-HSV.gB) protects mice against a vaccinia HSV.gB and HSV challenge.
    Endresz V, Berencsi K, Gönczöl E.
    Acta Microbiol Immunol Hung; 1995 Dec 01; 42(3):247-54. PubMed ID: 8548197
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 28. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P, Wigdorovitz A, Perez-Filgueira M, Carrillo C, Escribano JM, Sadir AM, Borca MV.
    Virology; 1995 Oct 01; 212(2):614-21. PubMed ID: 7571431
    [Abstract] [Full Text] [Related]

  • 29. Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.
    Chan WL, Tizard ML, Faulkner L.
    Immunology; 1989 Sep 01; 68(1):96-101. PubMed ID: 2553584
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant.
    Nesburn AB, Ramos TV, Zhu X, Asgarzadeh H, Nguyen V, BenMohamed L.
    Vaccine; 2005 Jan 04; 23(7):873-83. PubMed ID: 15603887
    [Abstract] [Full Text] [Related]

  • 32. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease.
    Lopes PP, Todorov G, Pham TT, Nesburn AB, Bahraoui E, BenMohamed L.
    J Virol; 2018 Apr 15; 92(8):. PubMed ID: 29437976
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.
    Whitbeck JC, Huang ZY, Cairns TM, Gallagher JR, Lou H, Ponce-de-Leon M, Belshe RB, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Jul 15; 88(14):7786-95. PubMed ID: 24789783
    [Abstract] [Full Text] [Related]

  • 36. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA, Knipe DM.
    Virology; 1997 Dec 22; 239(2):315-26. PubMed ID: 9434723
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D.
    Wyckoff JH, Osmand AP, Eisenberg RJ, Cohen GH, Rouse BT.
    Immunobiology; 1988 May 22; 177(2):134-48. PubMed ID: 2456985
    [Abstract] [Full Text] [Related]

  • 39. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB.
    J Virol; 2003 Sep 22; 77(17):9463-73. PubMed ID: 12915561
    [Abstract] [Full Text] [Related]

  • 40. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM.
    PLoS Pathog; 2018 May 22; 14(5):e1007095. PubMed ID: 29791513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.